Lung Academy podcast Mon, 09 Mar 2026 10:52:56 -0400 https://lungacademypodcast.buzzsprout.com en © 2026 Sanofi yes b5ca4fc2-d5f2-5a70-8b97-64d2aa516b3e Sanofi episodic false The Lung Academy offers you educational and future focused content created in collaboration with expert physicians that enables the exchange of knowledge, expertise, and best practices in Lung Cancer care.

Sanofi, MAT-BE-2200476, v1.0, July 2022 

]]> Buzzsprout (https://www.buzzsprout.com) Sanofi https://storage.buzzsprout.com/37v3odrgfa9fpr8ftg43ii8v2nfe?.jpg Lung Academy podcast ICI rechallenge now in the NSCLC ESMO guidelines: impact on clinical practice? ICI rechallenge now in the NSCLC ESMO guidelines: impact on clinical practice? In the fourth episode of the Lung Academy podcast series, Prof. Em. Johan Vansteenkiste, pulmonologist-oncologist at the University Hospital in Leuven, Belgium, and Dr. Willemijn Theelen, pulmonologist-oncologist at the Antoni van Leeuwenhoek Hospital in Amsterdam, the Netherlands, are invited to discuss the concept of Immune Checkpoint Inhibitors (ICI) rechallenge in the latest NSCLC ESMO guidelines and its impact on clinical practice. Both lung cancer experts provide further insights into the current gaps and the key questions that need to be answered before deciding to rechallenge. Finally, they also elaborate on which scientific hypotheses are currently being investigated in clinical trials.

Sanofi, MAT-BE-2300369, v1.0, 10/2023

]]> In the fourth episode of the Lung Academy podcast series, Prof. Em. Johan Vansteenkiste, pulmonologist-oncologist at the University Hospital in Leuven, Belgium, and Dr. Willemijn Theelen, pulmonologist-oncologist at the Antoni van Leeuwenhoek Hospital in Amsterdam, the Netherlands, are invited to discuss the concept of Immune Checkpoint Inhibitors (ICI) rechallenge in the latest NSCLC ESMO guidelines and its impact on clinical practice. Both lung cancer experts provide further insights into the current gaps and the key questions that need to be answered before deciding to rechallenge. Finally, they also elaborate on which scientific hypotheses are currently being investigated in clinical trials.

Sanofi, MAT-BE-2300369, v1.0, 10/2023

]]> Prof. Em. Johan Vansteenkiste & Dr. Willemijn Theelen Buzzsprout-13756242 Wed, 11 Oct 2023 09:00:00 +0200 1227 NSCLC, ESMO guidelines, lung cancer full false Advanced Care Planning: making patient care and quality of life top priority Advanced Care Planning: making patient care and quality of life top priority In this episode of the Lung Academy podcast, we will cover the topic Advanced Care Planning. Marloes Jansen, nurse practitioner in the Gelderse Vallei Hospital in the Netherlands, is an expert in advanced care planning. She shares her experience in helping patients and families make complex care decisions. Advanced Care Planning supports patients in thinking about and choosing future care options that suit their personal situations and preferences. The vital role of advanced care planning in healthcare will be discussed and how this approach can lead to better patient care and quality of life.

Sanofi, MAT-BE-2300367, v1.0, 05/2023

]]> In this episode of the Lung Academy podcast, we will cover the topic Advanced Care Planning. Marloes Jansen, nurse practitioner in the Gelderse Vallei Hospital in the Netherlands, is an expert in advanced care planning. She shares her experience in helping patients and families make complex care decisions. Advanced Care Planning supports patients in thinking about and choosing future care options that suit their personal situations and preferences. The vital role of advanced care planning in healthcare will be discussed and how this approach can lead to better patient care and quality of life.

Sanofi, MAT-BE-2300367, v1.0, 05/2023

]]> Marloes Jansen Buzzsprout-13291680 Wed, 26 Jul 2023 09:00:00 +0200 607 Marloes Jansen, Gelderse Vallei, care, cancer, oncology full false Sexuality and cancer: how can you support your patients? Sexuality and cancer: how can you support your patients? This Lung Academy podcast episode will focus on Sexuality in cancer patients. Corien Eeltink, nurse practitioner in the Dijklander hospital in Netherlands, is highly experienced in the topic of Sexuality in cancer patients. Improvements in the treatment of cancer have increased survival rates and life expectancy. Sexuality can be negatively affected not only during cancer treatment but also long after the cancer treatment. In this episode, Corien will talk about what kind of sexual problems cancer patients report, and discusses the information need patients have concerning changes in sexuality.

Sanofi, MAT-BE-2300368, v1.0, 05/2023

]]> This Lung Academy podcast episode will focus on Sexuality in cancer patients. Corien Eeltink, nurse practitioner in the Dijklander hospital in Netherlands, is highly experienced in the topic of Sexuality in cancer patients. Improvements in the treatment of cancer have increased survival rates and life expectancy. Sexuality can be negatively affected not only during cancer treatment but also long after the cancer treatment. In this episode, Corien will talk about what kind of sexual problems cancer patients report, and discusses the information need patients have concerning changes in sexuality.

Sanofi, MAT-BE-2300368, v1.0, 05/2023

]]> Corien Eeltink Buzzsprout-13291676 Wed, 26 Jul 2023 09:00:00 +0200 762 sexuality, cancer, Corien Eeltink, Dijklander, sexual problems, oncology full false Value Based Healthcare (VBHC) and the role of Patient Reported Outcomes Measures (PROMS) in Lung Cancer Value Based Healthcare (VBHC) and the role of Patient Reported Outcomes Measures (PROMS) in Lung Cancer In our first episode of the Lung Academy podcast, prof. Lore Decoster medical oncologists from the University hospital in Brussels, Belgium and prof. Ingel Demedts, pulmonologist & thoracic oncologist from AZ Delta in Roeselare, Belgium have been invited to discuss Value Based Healthcare and the role of Patient Reported Outcomes. Both lung cancer experts will provide more insights into the benefits of measuring PROs in daily clinical practice and what the value is in clinical trials. Furthermore, they elaborate on the current available tools to assess lung cancer patients, the potential barriers and share their personal expertise in implementing PROs in day-to-day practice. 

Sanofi, MAT-BE-2300366, v1.0, 05/2023

]]> In our first episode of the Lung Academy podcast, prof. Lore Decoster medical oncologists from the University hospital in Brussels, Belgium and prof. Ingel Demedts, pulmonologist & thoracic oncologist from AZ Delta in Roeselare, Belgium have been invited to discuss Value Based Healthcare and the role of Patient Reported Outcomes. Both lung cancer experts will provide more insights into the benefits of measuring PROs in daily clinical practice and what the value is in clinical trials. Furthermore, they elaborate on the current available tools to assess lung cancer patients, the potential barriers and share their personal expertise in implementing PROs in day-to-day practice. 

Sanofi, MAT-BE-2300366, v1.0, 05/2023

]]> Sanofi Buzzsprout-12986936 Tue, 06 Jun 2023 09:00:00 +0200 1631 Value Based Healthcare,Patient Reported Outcomes,lung cancer, full false